Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet
Product Details:
- CAS No 1051375-16-6 1434910-92-0 379270-37-8
- Medicine Type Antiretroviral
- Expiration Date 2 years from date of manufacture
- Origin of Medicine Synthetic
- Indication Treatment of HIV-1 infection
- Dosage Form Tablet
- Usage Used in combination as part of antiretroviral therapy for HIV infections
- Click to view more
X
Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet Product Specifications
- 1051375-16-6 1434910-92-0 379270-37-8
- Antiretroviral
- 2 years from date of manufacture
- Synthetic
- Treatment of HIV-1 infection
- C20H19F2N3O5 C8H10FN3O3S C21H29N6O5P
- Used in combination as part of antiretroviral therapy for HIV infections
- Tablet
- 30 tablets per box
- Film-coated tablet
- Greater than 99% purity
- Store below 30°C in a dry place protected from light
- Dolutegravir sodium Emtricitabine Tenofovir Alafenamide
- Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
- Pharmaceutical Grade
Other Products in 'HIV Medicine' category
Get in touch with us


